Igor Karpov

884 total citations
38 papers, 381 citations indexed

About

Igor Karpov is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Igor Karpov has authored 38 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Epidemiology, 16 papers in Infectious Diseases and 9 papers in Hepatology. Recurrent topics in Igor Karpov's work include Liver Disease Diagnosis and Treatment (8 papers), HIV/AIDS Research and Interventions (7 papers) and Hepatitis C virus research (7 papers). Igor Karpov is often cited by papers focused on Liver Disease Diagnosis and Treatment (8 papers), HIV/AIDS Research and Interventions (7 papers) and Hepatitis C virus research (7 papers). Igor Karpov collaborates with scholars based in Belarus, Russia and Denmark. Igor Karpov's co-authors include И. О. Стома, Amanda Mocroft, Ole Kirk, Jens Lundgren, Peré Domingo, Joanne Reekie, Alena Atrasheuskaya, G. M. Ignatyev, Jürgen K. Rockstroh and Daria Podlekareva and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Transplantation.

In The Last Decade

Igor Karpov

30 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Igor Karpov Belarus 13 230 170 76 50 39 38 381
Wang-Da Liu Taiwan 13 118 0.5× 172 1.0× 35 0.5× 30 0.6× 48 1.2× 49 452
Giuliano Stagni Italy 13 244 1.1× 120 0.7× 28 0.4× 101 2.0× 60 1.5× 42 508
Roberta Prinapori Italy 11 146 0.6× 215 1.3× 31 0.4× 24 0.5× 68 1.7× 24 311
Ingrid Steffen Switzerland 9 233 1.0× 146 0.9× 108 1.4× 13 0.3× 76 1.9× 15 418
Hartmut Stocker Germany 14 217 0.9× 263 1.5× 29 0.4× 42 0.8× 185 4.7× 38 513
Alice Namale Uganda 11 313 1.4× 324 1.9× 12 0.2× 21 0.4× 19 0.5× 21 509
P. Morlat France 10 158 0.7× 204 1.2× 38 0.5× 34 0.7× 175 4.5× 36 440
Chun-Yuan Lee Taiwan 10 103 0.4× 140 0.8× 11 0.1× 24 0.5× 59 1.5× 31 314
Alper Gündüz Türkiye 11 169 0.7× 171 1.0× 23 0.3× 27 0.5× 37 0.9× 48 328
Clifton A. Hawkes United States 10 292 1.3× 340 2.0× 41 0.5× 35 0.7× 246 6.3× 14 626

Countries citing papers authored by Igor Karpov

Since Specialization
Citations

This map shows the geographic impact of Igor Karpov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Igor Karpov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Igor Karpov more than expected).

Fields of papers citing papers by Igor Karpov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Igor Karpov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Igor Karpov. The network helps show where Igor Karpov may publish in the future.

Co-authorship network of co-authors of Igor Karpov

This figure shows the co-authorship network connecting the top 25 collaborators of Igor Karpov. A scholar is included among the top collaborators of Igor Karpov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Igor Karpov. Igor Karpov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Karpov, Igor, et al.. (2021). Microbiological efficiency of the combinations of two carbapenems against antibiotic resistant Klebsiella pneumoniae strains. Russian Clinical Laboratory Diagnostics. 66(5). 304–309. 2 indexed citations
2.
Podlekareva, Daria, Dorte Bek Folkvardsen, Alena Skrahina, et al.. (2021). Tuberculosis Drug Susceptibility, Treatment, and Outcomes for Belarusian HIV-Positive Patients with Tuberculosis: Results from a National and International Laboratory. SHILAP Revista de lepidopterología. 2021. 1–13. 2 indexed citations
3.
Стома, И. О., et al.. (2020). Clinical efficacy of pneumococcal vaccination in multiple myeloma patients on novel agents: Results of a prospective clinical study. Vaccine. 38(30). 4713–4716. 6 indexed citations
4.
Стома, И. О., et al.. (2020). GUT MICROBIOME DYNAMICS OVER A COURSE OF KIDNEY TRANSPLANTATION: PRELIMINARY RESULTS OF A PILOT STUDY. Transplantation. 104(S3). S191–S191. 3 indexed citations
5.
Karpov, Igor, et al.. (2019). RISK PREDICTION OF PORTAL HYPERTENSION IN PATIENTS WITH HCV-ASSOCIATED LIVER CIRRHOSIS. SHILAP Revista de lepidopterología. 3(1). 55–60.
6.
Colombo, Massimo, et al.. (2019). Consensus on management of hepatitis C virus infection in resource-limited Ukraine and Commonwealth of Independent States regions. World Journal of Gastroenterology. 25(29). 3897–3919. 3 indexed citations
7.
Karpov, Igor, et al.. (2019). Acute liver failure in adults. SHILAP Revista de lepidopterología. 21(1). 46–55.
8.
Стома, И. О., et al.. (2018). DECOLONIZATION OF INTESTINAL CARRIAGE OF MDR/XDR GRAM-NEGATIVE BACTERIA WITH ORAL COLISTIN IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES: RESULTS OF A RANDOMIZED CONTROLLED TRIAL. Mediterranean Journal of Hematology and Infectious Diseases. 10(1). 2018030–2018030. 13 indexed citations
10.
Мицура, В. М., et al.. (2018). RESULTS OF THE USE OF SOFOSBUVIR IN COMBINATION WITH LEDIPASVIR OR DACLATASVIR FOR CHRONIC HEPATITIS C TREATMENT IN THE REPUBLIC OF BELARUS. Journal Infectology. 10(3). 77–83. 1 indexed citations
11.
Krasko, О. V., et al.. (2017). Association of TNF-α and CCL5 with response to interferon-based therapy in patients with HCV 1 genotype. Clinical and Experimental Hepatology. 1. 16–22. 1 indexed citations
12.
Стома, И. О., et al.. (2016). Diagnostic value of sepsis biomarkers in hematopoietic stem cell transplant recipients in a condition of high prevalence of gram-negative pathogens. Hematology/Oncology and Stem Cell Therapy. 10(1). 15–21. 23 indexed citations
13.
Shepherd, Leah, Álvaro H. Borges, Bruno Ledergerber, et al.. (2016). Infection‐related and ‐unrelated malignancies, HIV and the aging population. HIV Medicine. 17(8). 590–600. 33 indexed citations
14.
15.
Grint, Daniel, Lars Peters, Juergen Rockstroh, et al.. (2015). Liver-related death among HIV/hepatitis C virus-co-infected individuals. AIDS. 29(10). 1205–1215. 25 indexed citations
16.
Laut, Kamilla Grønborg, Amanda Mocroft, Jeffrey V. Lazarus, et al.. (2014). Regional differences in self‐reported HIV care and management in the EuroSIDA study. Journal of the International AIDS Society. 17(4S3). 19504–19504. 4 indexed citations
17.
Søgaard, Ole S., Joanne Reekie, Matti Ristola, et al.. (2013). Severe bacterial non-aids infections in HIV-positive persons: Incidence rates and risk factors. Journal of Infection. 66(5). 439–446. 35 indexed citations
18.
Reekie, Joanne, Justyna Kowalska, Igor Karpov, et al.. (2012). Regional Differences in AIDS and Non-AIDS Related Mortality in HIV-Positive Individuals across Europe and Argentina: The EuroSIDA Study. PLoS ONE. 7(7). e41673–e41673. 35 indexed citations
20.
Podlekareva, Daria, Wendy Bannister, Amanda Mocroft, et al.. (2008). The EuroSIDA Study: Regional Differences in the HIV-1 Epidemic and Treatment Response to Antiretroviral Therapy among HIV-infected Patients across Europe - A Review of Published Results. Central European Journal of Public Health. 16(3). 99–105. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026